![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Experts Support Exondys 51 (Center for Duchenne Muscular Dystrophy UCLA) View |
![]() |
Exondys 51 (Phamfamily) View |
![]() |
Jenn McNarry Discusses the Sarepta AdCom and the Role of the Patient Advocate (CheckRare) View |
![]() |
Efficacy Data for Eteplirsen for Skipping Exon 51 (The France Foundation) View |
![]() |
ExonDys51 should be prescribed to DMD with amenable mutations. (Center for Duchenne Muscular Dystrophy UCLA) View |
![]() |
Is Eteplirsen Effective in Non-ambulatory Duchenne Patients (Rare Disease Report) View |
![]() |
ADCOM Response - Eteplirsen Approved! (Center for Duchenne Muscular Dystrophy UCLA) View |
![]() |
Abbreviated Response to the April 25th Advisory Committee (Center for Duchenne Muscular Dystrophy UCLA) View |
![]() |
First Duchenne Drug Approved by the FDA (CureDuchenneMD) View |
![]() |
Chris Garabedian Discusses His Time at Sarepta (CheckRare) View |